Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Susana Widjaja is active.

Publication


Featured researches published by Susana Widjaja.


PLOS Neglected Tropical Diseases | 2013

Evidence for Endemic Chikungunya Virus Infections in Bandung, Indonesia

Herman Kosasih; Quirijn de Mast; Susana Widjaja; Primal Sudjana; Ungke Antonjaya; Chairin Nisa Ma'roef; Silvita Fitri Riswari; Kevin R. Porter; Timothy Burgess; Bachti Alisjahbana; Andre van der Ven; Maya Williams

Chikungunya virus (CHIKV) is known to cause sporadic or explosive outbreaks. However, little is known about the endemic transmission of CHIKV. To ascertain the endemic occurrence of CHIKV transmission, we tested blood samples from patients with a non-dengue febrile illness who participated in a prospective cohort study of factory workers in Bandung, Indonesia. From August 2000 to June 2004, and September 2006 to April 2008, 1901 febrile episodes occurred and 231 (12.2%) dengue cases were identified. The remaining febrile cases were evaluated for possible CHIKV infection by measuring anti-CHIKV IgM and IgG antibodies in acute and convalescent samples. Acute samples of serologically positive cases were subsequently tested for the presence of CHIKV RNA by RT-PCR and/or virus isolation. A total of 135 (7.1%) CHIKV infections were identified, providing an incidence rate of 10.1/1,000 person years. CHIKV infections were identified all year round and tended to increase during the rainy season (January to March). Severe illness was not found and severe arthralgia was not a prominently reported symptom. Serial post-illness samples from nine cases were tested to obtain a kinetic picture of IgM and IgG anti-CHIKV antibodies. Anti-CHIKV IgM antibodies were persistently detected in high titers for approximately one year. Three patients demonstrated evidence of possible sequential CHIKV infections. The high incidence rate and continuous chikungunya cases in this adult cohort suggests that CHIKV is endemically transmitted in Bandung. Further characterization of the circulating strains and surveillance in larger areas are needed to better understand CHIKV epidemiology in Indonesia.


Journal of Immunology | 2006

CD40 Ligand Enhances Dengue Viral Infection of Dendritic Cells: A Possible Mechanism for T Cell-Mediated Immunopathology

Peifang Sun; Christina M. Celluzzi; Mary Marovich; Hemavathy Subramanian; Michael A. Eller; Susana Widjaja; Dupeh R. Palmer; Kevin R. Porter; Wellington Sun; Timothy Burgess

We have previously shown that dengue virus (DV) productively infects immature human dendritic cells (DCs) through binding to cell surface DC-specific ICAM-3-grabbing nonintegrin molecules. Infected DCs are apoptotic, refractory to TNF-α stimulation, inhibited from undergoing maturation, and unable to stimulate T cells. In this study, we show that maturation of infected DCs could be restored by a strong stimulus, CD40L. Addition of CD40L significantly reduced apoptosis of DCs, promoted IL-12 production, and greatly elevated the IFN-γ response of T cells, but yet did not restore T cell proliferation in MLR. Increased viral infection of DCs was also observed; however, increased infection did not appear to be mediated by DC-specific ICAM-3-grabbing nonintegrin, but rather was regulated by decreased production of IFN-α and decreased apoptotic death of infected DCs. Because CD40L is highly expressed on activated memory (but not naive) T cells, the observation that CD40L signaling results in enhanced DV infection of DC suggests a possible T cell-dependent mechanism for the immune-mediated enhancement of disease severity associated with some secondary dengue infections.


PLOS ONE | 2013

The diagnostic and prognostic value of dengue non-structural 1 antigen detection in a hyper-endemic region in indonesia

Herman Kosasih; Bachti Alisjahbana; Susana Widjaja; Nurhayati; Quirijn de Mast; Ida Parwati; Patrick J. Blair; Timothy Burgess; Andre van der Ven; Maya Williams

As dengue fever is undifferentiated from other febrile illnesses in the tropics and the clinical course is unpredictable, early diagnosis is important. Several commercial assays to detect dengue NS1 antigen have been developed; however, their performances vary and data is lacking from hyper-endemic areas where all four serotypes of dengue are equally represented. To assess the sensitivity of the Bio-Rad platelia Dengue NS1 antigen assay according to virus serotype, immune status, gender, and parameters of severe disease, acute sera from 220 individuals with confirmed dengue and 55 individuals with a non-dengue febrile illness were tested using the Bio-Rad platelia Dengue NS1 antigen assay. The overall sensitivity of the NS1 ELISA was 46.8% and the specificity was 100%. The sensitivity in primary infections was significantly higher than in secondary infections (100% vs. 35.7%). In secondary infections, the sensitivity of NS1 detection was highest in DENV-3 (47.1%), followed by DENV-1 (40.9%), DENV-2 (30%) and DENV-4 (27%) infections. NS1 was less frequently detected in sera with high titers of HI antibodies or in acute samples from patients whose pre-illness sera showed neutralizing antibodies to more than one serotype. The detection of NS1 was higher in females, severe cases, and individuals with lower platelet counts (<100,000/mm3). While the overall sensitivity of this NS1 ELISA is poor, our data suggest that in secondary infections, detection may be predictive of a more severe illness.


PLOS Neglected Tropical Diseases | 2016

The Epidemiology, Virology and Clinical Findings of Dengue Virus Infections in a Cohort of Indonesian Adults in Western Java

Herman Kosasih; Bachti Alisjahbana; Nurhayati; Quirijn de Mast; Irani Rudiman; Susana Widjaja; Ungke Antonjaya; Harli Novriani; Nugroho Harry Susanto; Hadi Jusuf; Andre van der Ven; Charmagne G. Beckett; Patrick J. Blair; Timothy Burgess; Maya Williams; Kevin R. Porter

Background Dengue has emerged as one of the most important infectious diseases in the last five decades. Evidence indicates the expansion of dengue virus endemic areas and consequently the exponential increase of dengue virus infections across the subtropics. The clinical manifestations of dengue virus infection include sudden fever, rash, headache, myalgia and in more serious cases, spontaneous bleeding. These manifestations occur in children as well as in adults. Defining the epidemiology of dengue in a given area is critical to understanding the disease and devising effective public health strategies. Methodology/Principal Findings Here, we report the results from a prospective cohort study of 4380 adults in West Java, Indonesia, from 2000–2004 and 2006–2009. A total of 2167 febrile episodes were documented and dengue virus infections were confirmed by RT-PCR or serology in 268 cases (12.4%). The proportion ranged from 7.6 to 41.8% each year. The overall incidence rate of symptomatic dengue virus infections was 17.3 cases/1,000 person years and between September 2006 and April 2008 asymptomatic infections were 2.6 times more frequent than symptomatic infections. According to the 1997 WHO classification guidelines, there were 210 dengue fever cases, 53 dengue hemorrhagic fever cases (including one dengue shock syndrome case) and five unclassified cases. Evidence for sequential dengue virus infections was seen in six subjects. All four dengue virus serotypes circulated most years. Inapparent dengue virus infections were predominantly associated with DENV-4 infections. Conclusions/Significance Dengue virus was responsible for a significant percentage of febrile illnesses in an adult population in West Java, Indonesia, and this percentage varied from year to year. The observed incidence rate during the study period was 43 times higher than the reported national or provincial rates during the same time period. A wide range of clinical severity was observed with most infections resulting in asymptomatic disease. The circulation of all four serotypes of dengue virus was observed in most years of the study.


Vector-borne and Zoonotic Diseases | 2011

Evidence of human hantavirus infection and zoonotic investigation of hantavirus prevalence in rodents in western Java, Indonesia.

Herman Kosasih; Ima Nurisa Ibrahim; Rudi Wicaksana; Bachti Alisjahbana; Yumilia Hoo; Iing H. Yo; Ungke Antonjaya; Susana Widjaja; Imelda Winoto; Maya Williams; Patrick J. Blair

During febrile surveillance in the western Java City of Bandung, Indonesia, a patient with clinical symptoms consistent with hantavirus infection was found to have elevated titers of hantavirus-specific immunoglobulin M (IgM) and IgG antibodies. A subsequent epizoological investigation demonstrated a higher prevalence of hantavirus IgG antibodies in rodents trapped in the vicinity of the patients home compared with rodents from a control area (13.2% vs. 4.7%, p = 0.036). The Old World Seoul hantavirus was detected by reverse transcriptase-polymerase chain reaction in the organs of 71% of the seropositive rodents tested. This is the first report of a Seoul virus infection in Indonesia supported by clinical, serological, and epizoological evidences. These findings suggest that hantavirus infection should be on the clinical differential diagnosis when acutely ill febrile patients report for care in western Java.


BioMed Research International | 2016

Comparison of the Hemagglutination Inhibition Test and IgG ELISA in Categorizing Primary and Secondary Dengue Infections Based on the Plaque Reduction Neutralization Test

Nurhayati Lukman; Gustiani Salim; Herman Kosasih; Nugroho Harry Susanto; Ida Parwati; Silvita Fitri; Bachti Alisjahbana; Susana Widjaja; Maya Williams

Secondary dengue infection by heterotypic serotypes is associated with severe manifestations of disease, that is, dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). The World Health Organization (WHO) has recommended criteria based on the hemagglutination inhibition (HI) test to distinguish between primary and secondary dengue infections. Since the HI test has practical limitations and disadvantages, we evaluated the accuracy of WHO HI criteria and compared it with criteria based on an IgG enzyme-linked immunosorbent assay (ELISA) using a plaque reduction neutralization test (PRNT) as the gold standard. Both WHO HI criteria and IgG ELISA criteria performed strongly (16/16) in determining primary infection. However, to determine secondary infection, the IgG ELISA criteria performed better (72/73) compared to the WHO HI criteria (23/73).


American Journal of Tropical Medicine and Hygiene | 2005

Epidemiology of dengue and dengue hemorrhagic fever in a cohort of adults living in Bandung, West Java, Indonesia

Kevin R. Porter; Charmagne G. Beckett; Herman Kosasih; Ratna Tan; Bachti Alisjahbana; Pandji Irani Fianza Rudiman; Susana Widjaja; Erlin Listiyaningsih; Chairin Nisa Ma’roef; James L. Mcardle; Ida Parwati; Primal Sudjana; Hadi Jusuf; Djoko Yuwono; Suharyono Wuryadi


American Journal of Tropical Medicine and Hygiene | 2005

EARLY DETECTION OF DENGUE INFECTIONS USING CLUSTER SAMPLING AROUND INDEX CASES

Charmagne G. Beckett; Herman Kosasih; Indra Faisal; Nurhayati; Ratna Tan; Susana Widjaja; Erlin Listiyaningsih; Chairin Nisa Ma’roef; Suharyono Wuryadi; Michael J. Bangs; Tatang K. Samsi; Djoko Yuwono; Curtis G. Hayes; Kevin R. Porter


Journal of Virological Methods | 2006

An immunocytometric assay based on dengue infection via DC-SIGN permits rapid measurement of anti-dengue neutralizing antibodies

Nicole Couillard Martin; Jorge Pardo; Monika Simmons; Jeffrey A. Tjaden; Susana Widjaja; Mary Marovich; Wellington Sun; Kevin R. Porter; Timothy Burgess


American Journal of Tropical Medicine and Hygiene | 2016

Clinical and Serological Insights from the Asian Lineage Chikungunya Outbreak in Grenada, 2014: An Observational Study.

C. N. L. Macpherson; Tp Noël; Paul J. Fields; Donald Jungkind; K Yearwood; Monika Simmons; Susana Widjaja; George Mitchell; Dolland Noel; Satesh Bidaisee; Todd E. Myers; A. Desiree LaBeaud

Collaboration


Dive into the Susana Widjaja's collaboration.

Top Co-Authors

Avatar

Kevin R. Porter

Naval Medical Research Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Maya Williams

Naval Medical Research Center

View shared research outputs
Top Co-Authors

Avatar

Timothy Burgess

Uniformed Services University of the Health Sciences

View shared research outputs
Top Co-Authors

Avatar

Monika Simmons

Naval Medical Research Center

View shared research outputs
Top Co-Authors

Avatar

Tp Noël

St. George's University

View shared research outputs
Top Co-Authors

Avatar

Charmagne G. Beckett

Naval Medical Research Center

View shared research outputs
Top Co-Authors

Avatar

George Mitchell

Naval Medical Research Center

View shared research outputs
Top Co-Authors

Avatar

Mary Marovich

Walter Reed Army Institute of Research

View shared research outputs
Researchain Logo
Decentralizing Knowledge